ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,373Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 1844

$619K Total Retail Price of All Prescriptions

Rank: 217 out of 1844

429 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 12,373 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 770 593 1 3
LISINOPRIL 768 619 2 4
LEVOTHYROXINE SODIUM 542 476 3 1
HYDROCODONE-ACETAMINOPHEN 529 423 S3 4 2
OMEPRAZOLE 444 322 5 5
WARFARIN SODIUM 418 379 6 13
POTASSIUM CHLORIDE 412 340 7 16
METFORMIN HCL 399 323 8 8
AMLODIPINE BESYLATE 374 359 9 6
FUROSEMIDE 362 294 10 7
METOPROLOL SUCCINATE 334 276 11 14
GLIMEPIRIDE 301 264 12 35
ZOLPIDEM TARTRATE 293 216 13 23
MELOXICAM 259 227 14 28
ALENDRONATE SODIUM 228 226 15 25
CITALOPRAM HBR 226 199 16 19
GABAPENTIN 225 209 17 15
METOPROLOL TARTRATE 218 142 18 11
CLONIDINE HCL 210 190 19 64
METHYLPREDNISOLONE 192 176 20 125
LISINOPRIL-HYDROCHLOROTHIAZIDE 171 162 21 20
HYDROCHLOROTHIAZIDE 170 143 22 9
CLOPIDOGREL 167 133 23 34
TRAMADOL HCL 152 80 24 18
TAMSULOSIN HCL 151 133 25 27
RANITIDINE HCL 144 99 26 38
LANTUS 133 92 27 42
LOSARTAN POTASSIUM 129 117 28 24
ATORVASTATIN CALCIUM 124 120 29 12
AZITHROMYCIN 122 109 30 37
LOSARTAN-HYDROCHLOROTHIAZIDE 121 119 31 47
PLAVIX 120 107 32 61
CARVEDILOL 117 74 33 22
CYCLOBENZAPRINE HCL 108 60 R 34 53
ADVAIR DISKUS 101 67 35 51
FINASTERIDE 96 82 36 137
ATENOLOL 95 78 37 17
PRAVASTATIN SODIUM 94 75 38 10
ISOSORBIDE MONONITRATE ER 92 86 39 59
PROAIR HFA 92 50 39 45
ZETIA 91 52 41 81
ALLOPURINOL 90 57 42 29
AMITRIPTYLINE HCL 89 75 R 43 72
OXYBUTYNIN CHLORIDE 87 65 44 103
DIOVAN 87 87 44 58
PREDNISONE 86 84 46 40
SERTRALINE HCL 85 44 47 21
INSULIN SYRINGE 85 61 47 111
DILTIAZEM 24HR CD 83 83 49 132
NEXIUM 79 53 50 31
ENALAPRIL MALEATE 78 69 51 69
PREMARIN 77 54 R 52 171
ESCITALOPRAM OXALATE 77 50 52 52
DIGOXIN 71 62 54 67
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 57 54 73
DOXYCYCLINE HYCLATE 70 47 56 90
HUMALOG 68 53 57 114
DONEPEZIL HCL 67 63 58 26
IBUPROFEN 67 42 58 89
CEPHALEXIN 65 51 60 56
TRIAMTERENE-HCTZ 64 60 61 48
TRILIPIX 62 20 62 167
CIPROFLOXACIN HCL 62 55 62 62
METOCLOPRAMIDE HCL 61 51 64 148
SPIRIVA 61 52 64 57
FLUOXETINE HCL 60 56 66 41
DIOVAN HCT 56 47 67 96
POLYETHYLENE GLYCOL 3350 54 39 68 39
NAMENDA 52 52 69 33
KETOCONAZOLE 51 26 70 231
PRAMIPEXOLE DIHYDROCHLORIDE 51 31 70 193
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 30, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.